WVE
Wave Life Sciences Ltd.
stockNASDAQ
Market OpenOct 5, 2026 2:43:11 PM EDT
3.75USD-0.794%(-0.03)2,086,720
3.7500Bid3.7600Ask0.0100SpreadPre-marketOct 5, 2026 9:19:30 AM EDT
3.87USD+2.381%(+0.09)
Loading…
Loading…
738.93M
Healthcare
Biotechnology
CEO
Paul Bolno
HQ
Singapore, 12 00 Marina One East Tower, Singapore
168
Previous Close
$3.78
Beta
1.30
52-Week High
$21.73 2025-12-09
52-Week Low
$3.56 2026-09-29
SMA 50
$4.96
SMA 200
$8.69
Avg. Vol 10D
3.58M
Avg. Vol 30D
3.37M
Avg. Vol 90D
3.19M
Relative Vol
0.61
197.05M
162.27M
82.35%
17,637,783
10.87%
5.17
57%/43%
34.64%
25.51%
0.4100%
3,400,000
16
37,246
130,300
Nov 9, 2026 (35d)
Oct 2, 2026
H.C. Wainwright reiterates Buy on Wave Life Sciences stock · 
Investing.com
Oct 1, 2026
Wave Life Sciences reaches FDA alignment on WVE-006 trial design · Investing.com
Sep 30, 2026
Wave to receive $12M milestone as GSK picks liver candidate · 
Seeking Alpha
WVE Profile
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave's pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
WVE Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.67 | 2026-09-28 | +2.18% | -2.800 |
| 1M | 4.86 | 2026-09-04 | -22.84% | 0.218 |
| 3M | 6.32 | 2026-07-06 | -40.66% | 0.801 |
| 6M | 7.09 | 2026-04-06 | -47.11% | 0.873 |
| 1Y | 7.22 | 2025-10-06 | -48.06% | 1.297 |
| 2Y | 8.41 | 2024-10-04 | -55.41% | — |
| 5Y | 4.68 | 2021-10-05 | -19.87% | 1.377 |
WVE Stock Summary
Wave Life Sciences Ltd. (NASDAQ:WVE) stock price today is $3.75, and today's volume is 2,060,619. WVE is down 0.794% today. The 30 day average volume is 3.37M. WVE market cap is $738.93M with 197.05M shares outstanding.